FindTrial
Sign In

Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution

Influence of Co-Vid 19 Pandemic on Screening Mammography in a Single Institution

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04750018
Enrollment
600
Registered
2021-02-11
Start date
2020-07-03
Completion date
2021-06-01
Last updated
2021-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, COVID-19

Keywords

COVID-19, Breast Cancer

Brief summary

To assess whether the COVID-19 pandemic delayed breast cancer diagnosis in Taiwan, an Asian country with a low COVID-19 incidence.

Detailed description

The institutional review board approved this retrospective study at a public academic medical center. The monthly volume of breast biopsies and breast cancers during the COVID-19 pandemic (between January 1 and July 31, 2020) was compared to the same period a year earlier (pre-COVID-19).

Interventions

OTHERsurgery

Patients were divided into surgery and no disease.

Sponsors

Chen-Pin Chou
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Receiving breast exam 2019-2020

Exclusion criteria

* lost clinical follow-up

Design outcomes

Primary

MeasureTime frameDescription
breast cancer1 yearBreast cancer or not

Countries

Taiwan

Contacts

Primary ContactChen-Pin Chou, MD
chouchenpin@gmail.com*886-3422121

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026